ReDREAM (Resistant Depression Response to Esketamine Assessing Metabolomics) Project: Untargeted metabolomics to identify biomarkers of treatment response to intranasal esketamine in individuals with Treatment-Resistant Depression

Research Project: 

ReDREAM (Resistant Depression Response to Esketamine Assessing Metabolomics) Project: Untargeted metabolomics to identify biomarkers of treatment response to intranasal esketamine in individuals with Treatment-Resistant Depression

Principal Investigator: 

UMBERTO ALBERT

Project Start Date: 

09/27/2023

Project End Date: 

10/20/2025

Funders: 

MINISTERO DELL'UNIVERSITA' E DELLA RICERCA

Acronym: 

ReDREAM

Person	Position
Prof. Umberto Albert	Research projects - Scientific Actor;

Last update: 12-06-2024 - 20:30